trial
as of 2026-07-01Perception Processing in Schizophrenia Patients and Normal Population
NCTId NCT01298349
at a glance
Phase — · Completed
Enrollment 71 (actual)
Sponsored by HaEmek Medical Center, Israel
Primary completion 2016-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
71 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2011-02
Primary completion
2016-12
Eligibility
ALL · 18 Years · 80 Years
Interventions & indications
Drugs
—
Indications
Sponsors
HaEmek Medical Center, IsraelLead Sponsor
Investigators
3
Sites
1 total
Afula, Israel
Facts & assertions
4 sourced
Enrollment
71
Phase
NA
Primary Completion Date
2016-12
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
indication
investigator